rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Charlotte McKee

CMO and Head of R&D

Company insider

Files Form 4 as: CMO and Head of R&D, Sionna Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
11
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
6 Feb 2025
Last trade
17 Sep 2026
Last filed
18 Sep 2026

Companies traded

Where they are an officer
SION Sionna TherapeuticsOfficer · Biotechnology · last 17 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
17 Sep 2026filed 18 Sep 2026SION Sionna TherapeuticsBiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
17 Sep 2026filed 18 Sep 2026SION Sionna TherapeuticsBiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
17 Sep 2026filed 18 Sep 2026SION Sionna Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—155,700 at $0.00filing
17 Sep 2026filed 18 Sep 2026SION Sionna Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—155,700 at $0.00filing
17 Sep 2026filed 18 Sep 2026SION Sionna Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—155,700 at $0.00filing
17 Sep 2026filed 18 Sep 2026SION Sionna Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—155,700 at $0.00filing
17 Sep 2026filed 18 Sep 2026SION Sionna TherapeuticsBiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
17 Sep 2026filed 18 Sep 2026SION Sionna TherapeuticsBiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
2 Jan 2026filed 6 Jan 2026SION Sionna Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—155,700 at $0.00filing
2 Jan 2026filed 6 Jan 2026SION Sionna Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—155,700 at $0.00filing
6 Feb 2025filed 10 Feb 2025SION Sionna Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—148,536 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

RA CAPITAL MANAGEMENT, L.P.Director and 10% owner · Director and 10% owner at Sionna Therapeutics, filing Form 4 there in the last year
Elena RidloffCFO and CBO · CFO and CBO at Sionna Therapeutics, filing Form 4 there in the last year
Michael CloonanPresident & CEO · President & CEO at Sionna Therapeutics, filing Form 4 there in the last year
Jennifer FitzpatrickCLO and Head of Program Mgmt. · CLO and Head of Program Mgmt. at Sionna Therapeutics, filing Form 4 there in the last year
ORBIMED ADVISORS LLCDirector and 10% owner · Director at Sionna Therapeutics, filing Form 4 there in the last year